Evidence Hub

Surgical site infection with Mycobacterium fortuitum following Mohs micrographic surgery in an immunocompromised patient and review

Gao DX, Plotnikova NE

Dermatology online journal, 2026

Abstract

Mycobacterium fortuitum (M. fortuitum) is a rare infection typically occurring in immunocompromised patients and in healthcare settings, primarily after surgery or exposure to contaminated medical equipment or tap water. A few cases have been reported following cutaneous procedures, including acupuncture, mesotherapy, and tattooing, although no report, to our knowledge, has been described after Mohs micrographic surgery (MMS). Treatment typically requires at least 2 oral antibiotics for several months owing to the persistent nature of the infection. We present a patient who had previously undergone MMS with bilobed flap and developed infection with M. fortuitum, treated with moxifloxacin 400 mg daily and trimethoprim-sulfamethoxazole 400 mg/80 mg daily.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free